Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
GSK PLC Sponsored ADR (GSK) had Weighted-Average Shares Outstanding (Diluted) of 2.06B for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
$43.08B |
|
$7.54B |
|
$11.89B |
|
$31.19B |
|
$32.62B |
|
$10.46B |
|
$-700.23M |
|
$9.76B |
|
$9.76B |
|
$8.29B |
|
$8.29B |
|
$8.29B |
|
$8.29B |
|
$10.46B |
|
$15.44B |
|
2.03B |
|
|
Weighted-Average Shares Outstanding (Diluted) |
2.06B |
$3.72 |
|
$3.66 |
|
| Balance Sheet Financials | |
$23.09B |
|
$12.29B |
|
$57.51B |
|
$80.60B |
|
$28.21B |
|
$19.40B |
|
$31.35B |
|
$59.56B |
|
$21.04B |
|
$-10.30B |
|
$21.04B |
|
-- |
|
| Cash Flow Statement Financials | |
$10.21B |
|
$-5.58B |
|
$-4.86B |
|
$4.49B |
|
$4.23B |
|
$-258.47M |
|
-- |
|
$-3.38B |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|